Gershell Leland Insider Trades

Insider Trading History

Track insider trading activity for Gershell Leland. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Capricor Therapeutics
Capricor Therapeutics CAPR
CHIEF FINANCIAL OFFICER
Holding Value $58k 2,100 shares
Last Trade
Mar 16, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$52.5k 2,100 shares
$25.00
$27.64
Capricor Therapeutics
Capricor Therapeutics CAPR
CHIEF FINANCIAL OFFICER
Holding Value $29k 1,050 shares
Last Trade
Mar 16, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$26.3k 1,050 shares
$25.00
$27.64
Capricor Therapeutics
Capricor Therapeutics CAPR
CHIEF FINANCIAL OFFICER
Holding Value $4.6M 166,500 shares
Last Trade
Mar 02, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.65M 166,500 shares
$21.90
$27.64
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $220k 19,260 shares
Last Trade
Sep 28, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.48T 400 shares
$3,705,600,000.00
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $215k 18,860 shares
Last Trade
Jul 17, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.54T 1,000 shares
$5,542,400,000.00
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $570k 50,000 shares
Last Trade
Feb 25, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$200T 50,000 shares
$3,993,600,000.00
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $204k 17,860 shares
Last Trade
Feb 09, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$18.3T 5,000 shares
$3,667,200,000.00
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $147k 12,860 shares
Last Trade
Dec 17, 2014 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$13.9T 3,530 shares
$3,936,000,000.00
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Dec 17, 2014 Sale (In The Money)Reported as In The Money on SEC Form 4.
$13.9T 3,530 shares
$3,936,000,000.00
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $433k 38,000 shares
Last Trade
Oct 29, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$179T 38,000 shares
$4,723,200,000.00
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $342k 30,000 shares
Last Trade
Jun 17, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$212T 30,000 shares
$7,078,399,999.00
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $365k 32,000 shares
Last Trade
Feb 11, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$301T 32,000 shares
$9,414,400,000.00
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
CFO And Treasurer
Holding Value $106k 9,330 shares
Last Trade
Sep 06, 2013 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.1T 500 shares
$2,201,600,000.00
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
CFO And Treasurer
Holding Value $101k 8,830 shares
Last Trade
Aug 14, 2013 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$8.47T 3,530 shares
$2,400,000,000.00
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
CFO And Treasurer
Holding Value $40.2k 3,530 shares
Last Trade
Aug 14, 2013 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$8.47T 3,530 shares
$2,400,000,000.00
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
CFO And Treasurer
Holding Value $60.4k 5,300 shares
Last Trade
May 24, 2013 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$719B 150 shares
$4,793,600,000.00
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
CFO And Treasurer
Holding Value $58.7k 5,150 shares
Last Trade
May 23, 2013 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$208B 50 shares
$4,160,000,000.00
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
CFO And Treasurer
Holding Value $1.14M 100,100 shares
Last Trade
May 21, 2013 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$479B 100 shares
$4,793,600,000.00
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
CFO And Treasurer
Holding Value $58.1k 5,100 shares
Last Trade
May 21, 2013 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$479B 100 shares
$4,793,600,000.00
$11.40
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
CFO And Treasurer
Holding Value $1.14M 100,000 shares
Last Trade
Apr 26, 2013 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$168T 37,500 shares
$4,480,000,000.00
$11.40

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up